Persistence, switching, and healthcare use after initiating calcitonin gene-related peptide inhibitors: a real-world assessment. [PDF]
Moura CS +7 more
europepmc +1 more source
Nociceptive Nerve-Derived CGRP Exacerbates Uterine Fibrogenesis in Adenomyosis by Promoting CD140b<sup>+</sup> CD146<sup>+</sup> Fibroblast Differentiation. [PDF]
Ye Z +11 more
europepmc +1 more source
Adverse events associated with gepants: a pharmacovigilance analysis based on the FDA adverse event reporting system. [PDF]
Song Q, Gao S, Tan Y.
europepmc +1 more source
Head-to-head relief: ubrogepant, rimegepant, and zavegepant in migraine treatment. [PDF]
Pellesi L +5 more
europepmc +1 more source
CGRP-Targeted Migraine Therapies in Patients With Vascular Risk Factors or Stroke: A Review. [PDF]
Eller MT +6 more
europepmc +1 more source
A Systems Biology and Drug Repositioning Approach for the Analysis of Mutual Genes Between Celiac Disease and Irritable Bowel Syndrome. [PDF]
Al-Madhagi H.
europepmc +1 more source
Expert consensus on gepants for acute and preventive treatment of migraine in Thailand. [PDF]
Anukoolwittaya P +14 more
europepmc +1 more source
Correction: Increased infection risk in patients on preventive CGRP-targeting therapies- a meta-analysis and clinical effect assessment. [PDF]
Straburzyński M +9 more
europepmc +1 more source
Migraine management in Chinese headache centers: a national survey and the role of quality control inspections. [PDF]
Ran Y, Wang X, He Z, Yu S, Dong Z.
europepmc +1 more source

